Step 1: Understanding plasma protein binding. Many drugs bind to plasma proteins, primarily albumin. Only the free (unbound) drug is available for pharmacological action. The protein-bound fraction serves as a reservoir, gradually releasing the drug as the free form is metabolized or excreted.
Step 2: Pharmacodynamic and pharmacokinetic implications.
- Pharmacodynamically inert: Since bound drugs cannot interact with receptors or target tissues, they are pharmacodynamically inactive.
- Pharmacokinetically active: Plasma-bound drugs can influence drug distribution and half-life but are not inert in pharmacokinetic terms.
Step 3: Why other options are incorrect. - (A) Pharmacodynamically active: Incorrect, as only free drugs interact with receptors.
- (B) Pharmacokinetically inert: Incorrect, as binding affects drug distribution and elimination.
- (C) Pharmacokinetically and pharmacodynamically inert: Incorrect, because plasma-bound drugs influence pharmacokinetics but not pharmacodynamics.
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil